We talk to a researcher about the Biden administration’s expanded IRS funding and why House Republicans want to rescind it. Then, a doctor helps us better understand a new drug treatment for early Alzheimer’s.
Featured in this Show
-
Why House Republicans voted to rescind IRS funding
As their first order of business after electing a speaker, Republicans in the House of Representatives voted to rescind tens of billions of dollars of funding for the IRS. We talk about the original sum of funding and its intended purpose, and how the agency could falter if further defending efforts succeed.
-
FDA approves drug to help with early Alzheimer's
The Food and Drug Administration approved a drug called lecanemab to be used for people with early Alzheimer’s in an effort to slow the cognitive decline of the disease. A geriatrician joins us to talk about the drug.
Episode Credits
- Rob Ferrett Host
- Sarah Hopefl Technical Director
- Tim Peterson Producer
- Emilie Burditt Producer
- Steven Rosenthal Guest
- Dr. Nathaniel Chin Guest
Wisconsin Public Radio, © Copyright 2024, Board of Regents of the University of Wisconsin System and Wisconsin Educational Communications Board.
